References
- CDCLeading Causes of Death2012 Available from: http://www.cdc.gov/nchs/fastats/lcod.htmAccessed January 19, 2016
- CDCCancer Among Women: Data and Statistics; Data by Demographic Atlanta2012 Available from: http://www.cdc.gov/cancer/dcpc/data/women.htmAccessed March 30, 2012
- Breastcancer.orgBreast Cancer Survival Triples in Last 60 Years2010 Available from: http://www.breastcancer.org/symptoms/new_research/20100930.jspAccessed February 15, 2016
- BertosNRParkMBreast cancer – one term, many entities?J Clin Invest2011121103789379621965335
- SnijdersAMFridlyandJMansDAShaping of tumor and drug-resistant genomes by instability and selectionOncogene200322284370437912853973
- LugerNMMachDBSevcikMAMantyhPWBone cancer pain: from model to mechanism to therapyJ Pain Symptom Manage2005295 SupplS32S4615907645
- Galve-RoperhISánchezCCortésMLGómez del PulgarTIzquierdoMGuzmánMAnti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activationNat Med20006331331910700234
- ShrivastavaAKuzontkoskiPMGroopmanJEPrasadACannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagyMol Cancer Ther20111071161117221566064
- McAllisterSDChristianRTHorowitzMPGarciaADesprezPYCannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cellsMol Cancer Ther20076112921292718025276
- BlazquezCSalazarMCarracedoACannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expressionCancer Res20086861945195218339876
- PreetAQamriZNasserMWCannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasisCancer Prev Res (Phila)201141657521097714
- SarnataroDPisantiSSantoroAThe cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanismMol Pharmacol20067041298130616822929
- WangDWangHNingWBacklundMGDeySKDuBoisRNLoss of cannabinoid receptor 1 accelerates intestinal tumor growthCancer Res200868156468647618676872
- OfekOKarsakMLeclercNPeripheral cannabinoid receptor, CB2, regulates bone massProc Natl Acad Sci USA2006103369670116407142
- StellaNCannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomasGlia20105891017103020468046
- MalanTPJrIbrahimMMDengHCB2 cannabinoid receptor-mediated peripheral antinociceptionPain200193323924511514083
- CaffarelMMAndradasCMiraECannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibitionMol Cancer2010919620649976
- HowlettACThe cannabinoid receptorsProstaglandins Other Lipid Mediat200268–69619631
- MelckDRuedaDGalve-RoperhIDe PetrocellisLGuzmánMDi MarzoVInvolvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cellsFEBS Lett1999463323524010606728
- LaucknerJEHilleBMackieKThe cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteinsProc Natl Acad Sci U S A200510252191441914916365309
- PalazuelosJOrtegaZDíaz-AlonsoJGuzmánMGalve-RoperhICB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signalingJ Biol Chem201228721198120922102284
- SanchezMGRuiz-LlorenteLSanchezAMDiaz-LaviadaIActivation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF inductionCell Signal200315985185912834810
- Ellert-MiklaszewskaAKaminskaBKonarskaLCannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad proteinCell Signal2005171253715451022
- HerreraBCarracedoADiez-ZaeraMGuzmánMVelascoGp38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cellsFEBS Lett2005579225084508816139274
- VelascoGGalve-RoperhISánchezCBlázquezCHaroAGuzmánMCannabinoids and ceramide: two lipids acting hand-by-handLife Sci200577141723173115958274
- MassiPVaccaniACerutiSColomboAAbbracchioMPParolaroDAntitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell linesJ Pharmacol Exp Ther2004308383884514617682
- PatwardhanAMJeskeNAPriceTJGamperNAkopianANHargreavesKMThe cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinProc Natl Acad Sci U S A200610330113931139816849427
- SharirHAboodMEPharmacological characterization of GPR55, a putative cannabinoid receptorPharmacol Ther2010126330131320298715
- SkehanPStorengRScudieroDNew colorimetric cytotoxicity assay for anticancer-drug screeningJ Natl Cancer Inst19908213110711122359136
- BurnetteWN“Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnal Biochem198111221952036266278
- TaoKFangMAlroyJSahagianGGImagable 4T1 model for the study of late stage breast cancerBMC Cancer2008822818691423
- VanderahTWGardellLRBurgessSEDynorphin promotes abnormal pain and spinal opioid antinociceptive toleranceJ Neurosci200020187074707910995854
- TallaridaRJMurrayRBManual of Pharmacological Calculations with Computer Programs2nd edNew York, NYSpringer-Verlag Publishers1987
- QamriZPreetANasserMWSynthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancerMol Cancer Ther20098113117312919887554
- GreenhoughAPatsosHAWilliamsACParaskevaCThe cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cellsInt J Cancer2007121102172218017583570
- MatsudaLALolaitSJBrownsteinMJYoungACBonnerTIStructure of a cannabinoid receptor and functional expression of the cloned cDNANature199034662845615642165569
- MunroSThomasKLAbu-ShaarMMolecular characterization of a peripheral receptor for cannabinoidsNature1993365644161657689702
- WessJMolecular basis of receptor/G-protein-coupling selectivityPharmacol Ther19988032312649888696
- CoddEEMabusJRMurrayBSZhangSPFloresCMDynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptorsAssay Drug Dev Technol20119436237221323580
- HoBYUezonoYTakadaSTakaseIIzumiFCoupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channelsReceptors Channels19996536337410551268
- GrimaldiCPisantiSLaezzaCAnandamide inhibits adhesion and migration of breast cancer cellsExp Cell Res2006312436337316343481
- LigrestiACascioMGPryceGNew potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisBr J Pharmacol20061471839116284631
- CaffarelMMSarrioDPalaciosJGuzmanMSanchezCDelta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulationCancer Res200666136615662116818634
- McAllisterSDMuraseRChristianRTPathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasisBreast Cancer Res Treat20111291374720859676
- MelckDBisognoTDe PetrocellisLUnsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptorsBiochem Biophys Res Commun1999262127528410448105
- HallsMLCooperDMRegulation by Ca2+-signaling pathways of adenylyl cyclasesCold Spring Harb Perspect Biol201131a00414321123395
- MasadaNSchaksSJacksonSESinzACooperDMDistinct mechanisms of calmodulin binding and regulation of adenylyl cyclases 1 and 8Biochemistry201251407917792922971080
- HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
- Curto-ReyesVLlamesSHidalgoAMenéndezLBaamondeASpinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced painBr J Pharmacol2010160356157320233215
- ClaytonNMarshallFHBountraCO’ShaughnessyCTCB1 and CB2 cannabinoid receptors are implicated in inflammatory painPain200296325326011972997
- Romero-SandovalANutile-McMenemyNDeLeoJASpinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injuryAnesthesiology2008108472273418362605
- YamamotoWMikamiTIwamuraHInvolvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic painEur J Pharmacol20085831566118279850
- IbrahimMMDengHZvonokAActivation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNSProc Natl Acad Sci U S A200310018105291053312917492
- Lozano-OndouaANHanlonKELargent-MilnesTMDisease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonistsJ Bone Miner Res20132819210722903605
- RibeiroRWenJLiSZhangYInvolvement of ERK1/2, cPLA(2) and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonistsProstaglandins Other Lipid Mediat2012100–101114
- FelderCCJoyceKEBrileyEMComparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptorsMol Pharmacol19954834434507565624
- BouaboulaMPoinot-ChazelCMarchandJSignaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expressionEur J Biochem199623737047118647116
- PertweeRGPharmacology of cannabinoid CB1 and CB2 receptorsPharmacol Ther19977421291809336020
- SanchezMGSanchezAMRuiz-LlorenteLDiaz-LaviadaIEnhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cellsFEBS Lett2003555356156614675774